NPCE
NeuroPace Inc
NASDAQ · Healthcare · Medical - Devices · US
$13.63
+10.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 39.37x
- Price / sales
- 4.73x
- Price / cash flow
- -41.61x
Enterprise value
- Enterprise value
- $486.0M
- EV / sales
- 4.92x
- EV / EBITDA
- -42.54x
- EV / EBIT
- -32.23x
- Market cap
- $467.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026